Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Faster global financial news!
UBS: Initiates coverage on Moderna (MRNA.O) with a Neutral rating and a price target of $34.
06/01/2026 20:15
Complaint Report
Complaint Report
UBS: Initiates coverage on Moderna (MRNA.O) with a Neutral rating and a price target of $34.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Previous: U.S. space-related stocks are trading lower in premarket trading, with AST SpaceMobile down nearly 4% and Rocket Lab down nearly 3%; autonomous driving technology company Mobileye continues to rise more than 11% after announcing it will acquire robotics startup MenTee for $900 million (cash and stock).
|
The new chief of staff to Ukrainian President Zelenskyy said that "concrete results" were achieved on the second day of the Paris talks.: Next
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
Scan to Download App
